Understanding Rare Genetic Diseases in Southeast Asia

Rare genetic diseases, defined as conditions affecting fewer than one in 200,000 people worldwide, pose significant challenges in Southeast Asia. Over 10 million individuals in the ASEAN region, many of them children, live with undiagnosed rare diseases due to low awareness, limited scientific knowledge, and the complexity of symptoms. Families often endure a diagnostic odyssey averaging 7.6 years, consulting multiple specialists and facing misdiagnoses. This delay not only prolongs suffering but also increases healthcare costs and emotional strain. Singapore's pioneering efforts in genomics are addressing these gaps head-on, leveraging advanced DNA sequencing to shorten diagnosis times to mere weeks and improve outcomes.

Launch and Evolution of the Genomics for Kids in ASEAN Programme

In 2022, Temasek Foundation partnered with KK Women's and Children's Hospital (KKH) to launch the Genomics for Kids in ASEAN (G4K) programme, a regional initiative aimed at democratizing access to genomic testing for underserved families. With over S$2.8 million in funding, the three-year effort has transformed paediatric care by providing comprehensive genetic testing, counselling, and support. By integrating clinical workflows with research, G4K has built infrastructure for sequencing, analysis, and interpretation, extending services beyond Singapore to Malaysia, the Philippines, and Vietnam. This collaboration exemplifies Singapore's role as a hub for precision medicine in the region.

Impressive Achievements in Diagnostics and Patient Care

Since inception, G4K has supported 510 families across four countries, achieving a remarkable 52% diagnostic success rate—surpassing global benchmarks of 25-40%. In Singapore, 53% of 214 families received diagnoses, enabling targeted therapies like enzyme replacement for Morquio A syndrome. Malaysia saw 52% success in 171 cases, including life-changing dietary interventions for severe malnutrition linked to DGAT1 mutations. The Philippines and Vietnam reported 49% and 53% rates respectively, with diagnoses facilitating early surveillance for cancers and heart conditions. A KKH-led study published in the American Journal of Medical Genetics highlights how early sequencing saves at least US$5,000 per patient by averting prolonged testing.

• Reduced diagnostic odyssey from years to weeks through rapid whole-genome sequencing.
• Empowered families with genetic counselling for informed planning and support group connections.
• Optimized treatments, such as Gleevec for fibrodysplasia ossificans progressiva in a Singapore patient.

The Groundbreaking ASEAN Genetic Registry

The programme's latest milestone is the establishment of ASEAN's first dedicated genetic registry—a comprehensive genomic database tailored to the region's multi-ethnic populations. Announced on February 27, 2026, at KKH's Rare Disease Day by Senior Minister of State Dr. Janil Puthucheary, this registry will aggregate sequenced genomes and variants to deepen epidemiological insights into rare diseases. No single ASEAN country encounters enough cases to fully interpret genetic variations; pooling data creates a powerful resource for accurate diagnostics and personalized treatments.Straits Times article Dr. Puthucheary emphasized, "Every genome sequenced will benefit children across the region for years to come."

Technical Workflow and Benefits of the Registry

The registry operates by securely storing anonymized genomic data from exome or whole-genome sequencing, enabling variant classification, pattern recognition, and AI-driven analysis. Step-by-step, families undergo clinical evaluation, sequencing at KKH labs, bioinformatics via PRISM at Duke-NUS, and multidisciplinary review. Benefits include:

• Tailored precision medicine for ASEAN's diverse genetics (e.g., distinguishing benign variants in Asian populations).
• Accelerated research into disease prevalence and novel mutations.
• Cost efficiencies and better resource allocation for rare disease management.
• Foundation for policy-making, training, and sustainable networks.

Strategic University Partnerships Driving Research

G4K thrives on academic collaborations, positioning Singapore universities at the forefront. Duke-NUS Medical School's PRISM provides bioinformatics expertise, while SingHealth Duke-NUS MCHRI leads clinical research. Regional partners include University of Malaya Medical Centre (Malaysia), University of the Philippines Manila's Institute of Human Genetics, and Hanoi Medical University's genetics departments (Vietnam). These ties facilitate knowledge transfer via workshops, symposia, and the Genetic Education for Medical Staff course. For aspiring researchers, opportunities abound in genomic medicine at institutions like Duke-NUS—explore higher-ed-jobs or university-jobs for roles in precision medicine.

Real-World Case Studies: Transforming Lives

Consider Ann, a three-year-old Indonesian diagnosed with Coffin-Siris syndrome via G4K—now managed by KKH specialists. Raphaella Gautama, 21, received fibrodysplasia ossificans progressiva diagnosis after years, accessing Gleevec therapy. Abigail Chua, 20, navigates myoclonus epilepsy with daily medication post-2019 diagnosis. In Vietnam, early detection prevented cardiac crises; in the Philippines, a 20-year quest ended with Menke-Hennekam Syndrome confirmation. These stories underscore the human impact, offering hope and actionable care plans.

Research Publications and Scientific Contributions

G4K fuels peer-reviewed research, including Nuraini Nazeha et al.'s 2022 paper in American Journal of Medical Genetics proving early sequencing's cost-effectiveness. Duke-NUS PRISM advances bioinformatics for variant interpretation, while Hanoi Medical University contributes epidemiological data. The registry will spawn studies on ASEAN-specific variants, enhancing global rare disease knowledge. Researchers at Singapore universities are pivotal; check higher-ed-career-advice for genomics career tips.

Role of Singapore's Higher Education in Genomics Leadership

Singapore's universities, notably Duke-NUS Medical School, anchor G4K's research arm. PRISM's computational pipelines analyze vast datasets, training regional experts. KKH's Genomic Medicine Department collaborates with academic institutes for symposia and certificates in clinical genomics. This positions Singapore as ASEAN's genomics hub, fostering PhD/postdoc opportunities. Aspiring academics can rate professors at rate-my-professor or pursue faculty positions via higher-ed-jobs/faculty.

Future Outlook: Scaling Precision Medicine Regionally

With the registry live, G4K eyes expansion to more ASEAN nations, integrating AI for faster variant calls and newborn screening pilots. Temasek Foundation's Kee Kirk Chuen highlights systemic impacts: building capabilities for future precision medicine. Challenges like data privacy and equity persist, but ethical frameworks ensure equitable access. By 2030, this could halve diagnostic times region-wide, saving lives and resources.

Photo by Jiachen Lin on Unsplash

Implications for Families, Researchers, and Policymakers

For families, the registry means faster answers and tailored care; for researchers, a treasure trove of data; for policymakers, a model for public-private partnerships. It promotes actionable insights like early interventions, reducing burdens. Professionals in genomics will find growing demand—visit higher-ed-jobs, university-jobs, and higher-ed-career-advice to advance your career in this vital field.